Anteris Technologies Ltd (AMEUF) Research

Anteris Technologies Ltd. is a medical device company focused on structural heart solutions. The firm manufactures and commercializes ADAPT, an advanced regenerative tissue product. Additionally, Anteris is actively developing DurAVRTM, a novel 3D, single-piece aortic valve designed to treat aortic stenosis. The company also conducts research and development in the broader field of regenerative medicines. Established in 1999, it changed its name from Admedus Limited to Anteris Technologies Ltd. in May 2020 and is headquartered in Toowong, Australia.

Market snapshot

Symbol
AMEUF
Price
$5.70
Day change
-35.81%
Market cap
$343.6M
P/E ratio
-3.87x
52-week range
5.55-15.53
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Carmat S.A. (CKMTF)
  • Cell MedX Corp. (CMXC)
  • China Medical & HealthCare Group Limited (COLRF)
  • Creso Pharma Limited (COPHF)
  • Eupraxia Pharmaceuticals Inc. (EPRXF)
  • Green Rain Energy Holdings Inc. (GREH)
  • Japan Medical Dynamic Marketing, Inc. (JMDMF)
  • Leafly Holdings, Inc. (LFLY)

Open Anteris Technologies Ltd (AMEUF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.